Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

T1978000

Tricaprylin

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

Glyceryl trioctanoate, 1,2,3-Tricapryloylglycerol, 1,2,3-Trioctanoylglycerol, Glycerol tricaprylate, Glycerol trioctanoate, Glyceryl tricaprylate, Tricaprylin, Trioctanoin

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Formula condensata:
[CH3(CH2)6COOCH2]2CHOCO(CH2)6CH3
Numero CAS:
Peso molecolare:
470.68
Beilstein:
1717202
Numero MDL:
Codice UNSPSC:
41116107
ID PubChem:
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

tricaprylin

Produttore/marchio commerciale

EDQM

P. eboll.

233 °C/1 mmHg (lit.)

Densità

0.956 g/mL at 20 °C (lit.)

applicazioni

pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

−20°C

Stringa SMILE

CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC

InChI

1S/C27H50O6/c1-4-7-10-13-16-19-25(28)31-22-24(33-27(30)21-18-15-12-9-6-3)23-32-26(29)20-17-14-11-8-5-2/h24H,4-23H2,1-3H3
VLPFTAMPNXLGLX-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Tricaprylin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

nwg

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Ci dispiace, ma al momento non ci sono COA disponibili online per questo prodotto.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 6

1 of 6

vibrant-m

Y0000794

Glycerol monocaprylate

Triolein European Pharmacopoeia (EP) Reference Standard

Y0001113

Triolein

Supelco

Supelco

17810

Triglyceride Mix

Trimyristin European Pharmacopoeia (EP) Reference Standard

T2500100

Trimyristin

Ken-Ichi Ogawara et al.
Journal of pharmaceutical sciences, 106(4), 1143-1148 (2017-01-09)
To develop a safer and more potent paclitaxel (PTX) formulation, we prepared various oil-in-water emulsions by using egg phosphatidylcholine, Tween 80, and a mixture of triglycerides with different fatty acid chain lengths as the cosurfactant, surfactant, and oil phase component
Sung Yong Lee et al.
Journal of biomedical science, 26(1), 41-41 (2019-05-28)
Endoplasmic reticulum stress has a profound effect on cancer cell proliferation and survival, and also has the capacity to activate cells of the adaptive immune system. Multimodal treatment methods that utilize and combine conventional cancer therapies with antigen-specific immunotherapies have
Li Huang et al.
Experimental animals, 68(3), 301-306 (2019-03-15)
Inflammation-related animal model is necessary to better understanding the association of inflammation with tumorigenesis. Although mouse models of inflammation-related lung tumorigenesis on A/J mice strain have been set up in previous study, there is no report on the model on
Ada W Y Leung et al.
Pharmaceutics, 11(3) (2019-03-20)
Liposomes are considered one of the most successful drug delivery systems (DDS) given their established utility and success in the clinic. In the past 40⁻50 years, Canadian scientists have made ground-breaking discoveries, many of which were successfully translated to the
Qi Zhang et al.
Oncotarget, 8(42), 72447-72456 (2017-10-27)
Gefitinib showed response in phase II clinical trials and with better clinical response in lung cancer with activating mutations in the tyrosine kinase domain of the EGFR. Questions of toxicity and potential dosing regimens impede the use in a prevention

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.